{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:58:26Z","timestamp":1791388706482,"version":"4.3.3"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s43032-026-02201-9","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:12:25Z","timestamp":1789485145000},"page":"1891-1906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Endocannabinoid System in Endometriosis-Associated Pain: Mechanisms, Molecular Targets, and Therapeutic Implications"],"prefix":"10.1007","volume":"33","author":[{"given":"Alexandra M.","family":"Stone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Veltre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia G.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia M.","family":"Biernat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-4256","authenticated-orcid":false,"given":"Husam M.","family":"Abu-Soud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2201_CR1","doi-asserted-by":"publisher","first-page":"879015","DOI":"10.3389\/fmed.2022.879015","volume":"9","author":"PG Signorile","year":"2022","unstructured":"Signorile PG, Viceconte R, Baldi A. New insights in pathogenesis of endometriosis. Front Med (Lausanne). 2022;9:879015. https:\/\/doi.org\/10.3389\/fmed.2022.879015","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2201_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0974-2727.66699","volume":"2","author":"N Agarwal","year":"2010","unstructured":"Agarwal N, Subramanian A. Endometriosis - morphology, clinical presentations and molecular pathology. J Lab Physicians. 2010;2(1):1\u20139. https:\/\/doi.org\/10.4103\/0974-2727.66699.","journal-title":"J Lab Physicians"},{"issue":"10","key":"2201_CR3","doi-asserted-by":"publisher","first-page":"e0258940","DOI":"10.1371\/journal.pone.0258940","volume":"16","author":"J Sinclair","year":"2021","unstructured":"Sinclair J, Collett L, Abbott J, Pate DW, Sarris J, Armour M. Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms. PLoS ONE. 2021;16(10):e0258940. https:\/\/doi.org\/10.1371\/journal.pone.0258940.","journal-title":"PLoS ONE"},{"key":"2201_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejogrb.2016.07","volume":"209","author":"M Morotti","year":"2017","unstructured":"Morotti M, Vincent K, Becker CM. Mechanisms of pain in endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017;209:8\u201313. https:\/\/doi.org\/10.1016\/j.ejogrb.2016.07.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"22","key":"2201_CR5","doi-asserted-by":"publisher","first-page":"7071","DOI":"10.3390\/jcm12227071","volume":"12","author":"T Farooqi","year":"2023","unstructured":"Farooqi T, Bhuyan DJ, Low M, Sinclair J, Leonardi M, Armour M. Cannabis and endometriosis: the roles of the gut microbiota and the endocannabinoid system. J Clin Med. 2023;12(22):7071. https:\/\/doi.org\/10.3390\/jcm12227071","journal-title":"J Clin Med"},{"key":"2201_CR6","doi-asserted-by":"publisher","first-page":"902371","DOI":"10.3389\/fgwh.2022.902371","volume":"3","author":"K Ellis","year":"2022","unstructured":"Ellis K, Munro D, Clarke J. Endometriosis is undervalued: a call to action. Front Glob Womens Health. 2022;3:902371. https:\/\/doi.org\/10.3389\/fgwh.2022.902371","journal-title":"Front Glob Womens Health"},{"issue":"3","key":"2201_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.fertnstert.2012.06","volume":"98","author":"RO Burney","year":"2012","unstructured":"Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.06.","journal-title":"Fertil Steril"},{"issue":"11","key":"2201_CR8","first-page":"1964","volume":"19","author":"I Soave","year":"2015","unstructured":"Soave I, Caserta D, Wenger JM, Dessole S, Perino A, Marci R. Environment and endometriosis: a toxic relationship. Eur Rev Med Pharmacol Sci. 2015;19(11):1964\u201372.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2201_CR9","doi-asserted-by":"publisher","first-page":"590823","DOI":"10.3389\/fncel.2020.590823","volume":"14","author":"J Maddern","year":"2020","unstructured":"Maddern J, Grundy L, Castro J, Brierley SM. Pain in endometriosis. Front Cell Neurosci. 2020;14:590823. https:\/\/doi.org\/10.3389\/fncel.2020.590823.","journal-title":"Front Cell Neurosci"},{"key":"2201_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.2975","author":"S As-Sanie","year":"2025","unstructured":"As-Sanie S, Mackenzie SC, Morrison L, Schrepf A, Zondervan KT, Horne AW, et al. Endometriosis: a review. JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2025.2975.","journal-title":"Endometriosis: Rev JAMA"},{"key":"2201_CR11","doi-asserted-by":"publisher","first-page":"4323259","DOI":"10.1155\/2022\/4323259","volume":"2022","author":"S Allam","year":"2022","unstructured":"Allam S, Paris E, Lazcano I, Bitterman P, Basu S, O\u2019Donnell J, et al. Detection of cannabinoid receptor expression by endometriotic lesions in women with endometriosis as an alternative to opioid-based pain medication. J Immunol Res. 2022;2022:4323259. https:\/\/doi.org\/10.1155\/2022\/4323259","journal-title":"J Immunol Res"},{"issue":"1","key":"2201_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/j.pain.0000000000002333","volume":"163","author":"T Andrieu","year":"2022","unstructured":"Andrieu T, Chicca A, Pellegata D, Bersinger NA, Imboden S, Nirgianakis K, et al. Association of endocannabinoids with pain in endometriosis. Pain. 2022;163(1):193\u2013203. https:\/\/doi.org\/10.1097\/j.pain.0000000000002333.","journal-title":"Pain"},{"issue":"4","key":"2201_CR13","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00404-024-07675-z","volume":"310","author":"C Chen","year":"2024","unstructured":"Chen C, Li X, Lu S, Yang J, Liu Y. Acupuncture for clinical improvement of endometriosis-related pain: a systematic review and meta-analysis. Arch Gynecol Obstet. 2024;310(4):2101\u201314. https:\/\/doi.org\/10.1007\/s00404-024-07675-z.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2201_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/imr.2024.0017","volume":"3","author":"S Calleson Cummings","year":"2024","unstructured":"Calleson Cummings S, Ennis N, Kloss K, Rosasco R. Evaluating the current evidence for the efficacy of cannabis in symptom management of endometriosis-associated pain. Integr Med Rep. 2024;3(1):111\u20137. https:\/\/doi.org\/10.1089\/imr.2024.0017.","journal-title":"Integr Med Rep"},{"issue":"17","key":"2201_CR15","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s40265-023-01951-z","volume":"83","author":"J Sinclair","year":"2023","unstructured":"Sinclair J, Abbott J, Proudfoot A, Armour M. The place of cannabinoids in the treatment of gynecological pain. Drugs. 2023;83(17):1571\u20139. https:\/\/doi.org\/10.1007\/s40265-023-01951-z.","journal-title":"Drugs"},{"issue":"8","key":"2201_CR16","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/jcm14082851","volume":"14","author":"P Simankowicz","year":"2025","unstructured":"Simankowicz P, Stepniewska J. The role of endocannabinoids in physiological processes and disease pathology: a comprehensive review. J Clin Med. 2025;14(8):2851. https:\/\/doi.org\/10.3390\/jcm14082851","journal-title":"J Clin Med"},{"issue":"15","key":"2201_CR17","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.3390\/ijms26157095","volume":"26","author":"P Kalak","year":"2025","unstructured":"Kalak P, Kupczyk P, Szumny A, Gebarowski T, Jasiak M, Niedzwiedz A, et al. Molecular mechanisms of the endocannabinoid system with a focus on reproductive physiology and the cannabinoid impact on fertility. Int J Mol Sci. 2025;26(15):7095. https:\/\/doi.org\/10.3390\/ijms26157095","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2201_CR18","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1089\/jwh.2020.8737","volume":"30","author":"AR Carrubba","year":"2021","unstructured":"Carrubba AR, Ebbert JO, Spaulding AC, DeStephano D, DeStephano CC. Use of cannabis for self-management of chronic pelvic pain. J Womens Health (Larchmt). 2021;30(9):1344\u201351. https:\/\/doi.org\/10.1089\/jwh.2020.8737.","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"2201_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s42238-022-00163-8","volume":"4","author":"H Lingegowda","year":"2022","unstructured":"Lingegowda H, Williams BJ, Spiess KG, Sisnett DJ, Lomax AE, Koti M, et al. Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications. J Cannabis Res. 2022;4(1):54. https:\/\/doi.org\/10.1186\/s42238-022-00163-8.","journal-title":"J Cannabis Res"},{"issue":"5","key":"2201_CR20","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s00404-024-07652-6","volume":"310","author":"V Jasinski","year":"2024","unstructured":"Jasinski V, Voltolini Velho R, Sehouli J, Mechsner S. Cannabis use in endometriosis: the patients have their say-an online survey for German-speaking countries. Arch Gynecol Obstet. 2024;310(5):2673\u201380. https:\/\/doi.org\/10.1007\/s00404-024-07652-6.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"2201_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/reprodmed6030023","volume":"6","author":"AE Reinert","year":"2025","unstructured":"Reinert AE, Bolshakova M, Wong AS, Cortessis VK. Self-reported use and effectiveness of marijuana for pelvic pain among women with endometriosis. Reproductive Med. 2025;6(3):23. https:\/\/doi.org\/10.3390\/reprodmed6030023.\u00a0","journal-title":"Reproductive Med"},{"key":"2201_CR22","first-page":"100192","volume":"18","author":"EC Yang","year":"2023","unstructured":"Yang EC, Koenig NA, Gong M, Brotto LA, Barr AM, Lee T, et al. Cannabis use preferences in women with myofascial pelvic pain: A cross-sectional study. Eur J Obstet Gynecol Reprod Biol X. 2023;18:100192.","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"issue":"4","key":"2201_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/can.2021.0116","volume":"7","author":"J Sinclair","year":"2022","unstructured":"Sinclair J, Toufaili Y, Gock S, Pegorer AG, Wattle J, Franke M, et al. Cannabis use for endometriosis: clinical and legal challenges in Australia and New Zealand. Cannabis Cannabinoid Res. 2022;7(4):464\u201372. https:\/\/doi.org\/10.1089\/can.2021.0116.\u00a0","journal-title":"Cannabis Cannabinoid Res"},{"key":"2201_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jconrel.2024.10.036","volume":"376","author":"Z Liao","year":"2024","unstructured":"Liao Z, Monsivais D, Matzuk MM. The long road of drug development for endometriosis - Pains, gains, and hopes. J Control Release. 2024;376:429\u201340. https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.036.\u00a0","journal-title":"J Control Release"},{"issue":"9","key":"2201_CR25","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s43032-020-00205-7","volume":"27","author":"CB Appleyard","year":"2020","unstructured":"Appleyard CB, Flores I, Torres-Reveron A. The link between stress and endometriosis: from animal models to the clinical scenario. Reprod Sci. 2020;27(9):1675\u201386. https:\/\/doi.org\/10.1007\/s43032-020-00205-7.\u00a0","journal-title":"Reprod Sci"},{"key":"2201_CR26","doi-asserted-by":"publisher","unstructured":"WeiY, Liang Y, Lin H, Dai Y, Yao S, Yao S. Autonomic nervous system and inflammation interaction in endometriosis-associated pain. J Neuroinflammation. 2020;17(1):80. https:\/\/doi.org\/10.1186\/s12974-020-01752-1.","DOI":"10.1186\/s12974-020-01752-1"},{"key":"2201_CR27","doi-asserted-by":"publisher","first-page":"729642","DOI":"10.3389\/frph.2021.729642","volume":"3","author":"HC McNamara","year":"2021","unstructured":"McNamara HC, Frawley HC, Donoghue JF, Readman E, Healey M, Ellett L, et al. Peripheral, central, and cross sensitization in endometriosis-associated pain and comorbid pain syndromes. Front Reprod Health. 2021;3:729642. https:\/\/doi.org\/10.3389\/frph.2021.729642.\u00a0","journal-title":"Front Reprod Health"},{"issue":"8","key":"2201_CR28","doi-asserted-by":"publisher","first-page":"e66128","DOI":"10.7759\/cureus.66128","volume":"16","author":"S Rathod","year":"2024","unstructured":"Rathod S, Shanoo A, Acharya N, Endometriosis. A comprehensive exploration of inflammatory mechanisms and fertility implications. Cureus. 2024;16(8):e66128. https:\/\/doi.org\/10.7759\/cureus.66128.","journal-title":"Cureus"},{"key":"2201_CR29","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1017\/erm.2022.26","volume":"24","author":"P Fan","year":"2022","unstructured":"Fan P, Li T. Unveil the pain of endometriosis: from the perspective of the nervous system. Expert Rev Mol Med. 2022;24:e36. https:\/\/doi.org\/10.1017\/erm.2022.26.\u00a0","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"2201_CR30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/AOG.0000000000006004","volume":"146","author":"ET Carey","year":"2025","unstructured":"Carey ET, Wong JMK, Khan Z. Comprehensive review of endometriosis care. Obstet Gynecol. 2025;146(3):323\u201340. https:\/\/doi.org\/10.1097\/AOG.0000000000006004.","journal-title":"Obstet Gynecol"},{"key":"2201_CR31","doi-asserted-by":"publisher","first-page":"1621178","DOI":"10.3389\/fimmu.2025.1621178","volume":"16","author":"M Golinska","year":"2025","unstructured":"Golinska M, Wolyniak M, Kulesza P, Fendler W. Neuroinflammation is responsible for pain in endometriosis - targeting the JAK-STAT pathway and mast cell activation. Front Immunol. 2025;16:1621178. https:\/\/doi.org\/10.3389\/fimmu.2025.1621178.\u00a0","journal-title":"Front Immunol"},{"issue":"11","key":"2201_CR32","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.3390\/ijms26115193","volume":"26","author":"JV De Garmendia","year":"2025","unstructured":"Garmendia JV, De Sanctis CV, Hajduch M, De Sanctis JB. Endometriosis: an immunologist\u2019s perspective. Int J Mol Sci. 2025;26(11):5193. https:\/\/doi.org\/10.3390\/ijms26115193","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2201_CR33","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.3390\/ijms23105427","volume":"23","author":"T Genovese","year":"2022","unstructured":"Genovese T, Cordaro M, Siracusa R, Impellizzeri D, Caudullo S, Raffone E, et al. Molecular and biochemical mechanism of cannabidiol in the management of the inflammatory and oxidative processes associated with endometriosis. Int J Mol Sci. 2022;23(10):5427. https:\/\/doi.org\/10.3390\/ijms23105427","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2201_CR34","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41598-020-79750-9","volume":"11","author":"M Hao","year":"2021","unstructured":"Hao M, Liu X, Rong P, Li S, Guo S-W. Reduced vagal tone in women with endometriosis and auricular vagus nerve stimulation as a potential therapeutic approach. Sci Rep. 2021;11(1):1345. https:\/\/doi.org\/10.1038\/s41598-020-79750-9.","journal-title":"Sci Rep"},{"issue":"5","key":"2201_CR35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2217\/whe.15.47","volume":"11","author":"EJ Miller","year":"2015","unstructured":"Miller EJ, Fraser IS. The importance of pelvic nerve fibers in endometriosis. Womens Health (Lond). 2015;11(5):611\u20138. https:\/\/doi.org\/10.2217\/whe.15.47.","journal-title":"Womens Health (Lond)"},{"issue":"12","key":"2201_CR36","doi-asserted-by":"publisher","first-page":"e75590","DOI":"10.7759\/cureus.75590","volume":"16","author":"HAD Al Hussaini","year":"2024","unstructured":"Al Hussaini HAD, Alatawi ESE, Shabani JAJ, Edhrabooh MIH, Alhawaj SAA, Almahfoodh MS, et al. Management of endometriosis-related pain: comparing the effectiveness of hormonal therapy, surgical interventions, and complementary therapies. Cureus. 2024;16(12):e75590. https:\/\/doi.org\/10.7759\/cureus.75590.\u00a0","journal-title":"Cureus"},{"issue":"23","key":"2201_CR37","doi-asserted-by":"publisher","first-page":"13102","DOI":"10.3390\/ijms222313102","volume":"22","author":"RV Velho","year":"2021","unstructured":"Velho RV, Taube E, Sehouli J, Mechsner S. Neurogenic inflammation in the context of endometriosis-what do we know? Int J Mol Sci. 2021;22(23):13102. https:\/\/doi.org\/10.3390\/ijms222313102","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2201_CR38","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1093\/humrep\/del260","volume":"21","author":"N Tokushige","year":"2006","unstructured":"Tokushige N, Markham R, Russell P, Fraser IS. Nerve fibres in peritoneal endometriosis. Hum Reprod. 2006;21(11):3001\u20137. https:\/\/doi.org\/10.1093\/humrep\/del260.\u00a0","journal-title":"Hum Reprod"},{"issue":"22","key":"2201_CR39","doi-asserted-by":"publisher","first-page":"12242","DOI":"10.3390\/ijms252212242","volume":"25","author":"M Garvey","year":"2024","unstructured":"Garvey M. Endometriosis: future biological perspectives for diagnosis and treatment. Int J Mol Sci. 2024;25(22):12242. https:\/\/doi.org\/10.3390\/ijms252212242","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2201_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/humupd\/dmq050","volume":"17","author":"P Stratton","year":"2011","unstructured":"Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327\u201346. https:\/\/doi.org\/10.1093\/humupd\/dmq050.\u00a0","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2201_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.fertnstert.2009.07.980","volume":"93","author":"B McKinnon","year":"2010","unstructured":"McKinnon B, Bersinger NA, Huber AW, Kuhn A, Mueller MD. PPAR-gamma expression in peritoneal endometriotic lesions correlates with pain experienced by patients. Fertil Steril. 2010;93(1):293\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.07.980.\u00a0","journal-title":"Fertil Steril"},{"issue":"13","key":"2201_CR42","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.7150\/ijbs.116635","volume":"21","author":"J Wang","year":"2025","unstructured":"Wang J, Mao X, Zhu L, Zhang X. Unravelling the intricate link: mast cells and estrogen-induced pain sensitization in endometriosis. Int J Biol Sci. 2025;21(13):5891\u2013904. https:\/\/doi.org\/10.7150\/ijbs.116635.\u00a0","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2201_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/can.2016.0035","volume":"2","author":"J Bouaziz","year":"2017","unstructured":"Bouaziz J, Bar On A, Seidman DS, Soriano D. The clinical significance of endocannabinoids in endometriosis pain management. Cannabis Cannabinoid Res. 2017;2(1):72\u201380. https:\/\/doi.org\/10.1089\/can.2016.0035.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"2201_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/ph18010073","volume":"18","author":"B Grimling","year":"2025","unstructured":"Grimling B, Fast M, Okoniewska M, Owczarek A, Karolewicz B. Optimization and evaluation of cannabis-based magistral formulations: a path to personalized therapy. Pharmaceuticals (Basel). 2025;18(1):73. https:\/\/doi.org\/10.3390\/ph18010073","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2201_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jogc.2022.11.003","volume":"45","author":"M Gholiof","year":"2023","unstructured":"Gholiof M, Adamson-De Luca E, Foster WG, Leyland NA, Bridge-Cook P, Leonardi M, et al. Prevalence of use and perceived effectiveness of medical, surgical, and alternative therapies for endometriosis pain in Canadians. J Obstet Gynaecol Can. 2023;45(1):11\u201320.","journal-title":"J Obstet Gynaecol Can"},{"issue":"12","key":"2201_CR46","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.tips.2024.10.014","volume":"45","author":"LHR Whitaker","year":"2024","unstructured":"Whitaker LHR, Page C, Morgan C, Horne AW, Saunders PTK. Endometriosis: cannabidiol therapy for symptom relief. Trends Pharmacol Sci. 2024;45(12):1150\u201361. https:\/\/doi.org\/10.1016\/j.tips.2024.10.014.\u00a0","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"2201_CR47","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/AOG.0000000000005606","volume":"144","author":"A-ME Amies Oelschlager","year":"2024","unstructured":"AmiesOelschlager A-ME, Gecsi K, Rodriguez M. ACOG clinical consensus 7: the use of cannabis products for the management of pain associated with gynecologic conditions. Obstet Gynecol. 2024;144(1):e24\u201334. https:\/\/doi.org\/10.1097\/AOG.0000000000005606.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2201_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/can.2021.0162","volume":"7","author":"M Armour","year":"2022","unstructured":"Armour M, Sinclair J, Cheng J, Davis P, Hameed A, Meegahapola H, et al. Endometriosis and cannabis consumption during the COVID-19 pandemic: an international cross-sectional survey. Cannabis Cannabinoid Res. 2022;7(4):473\u201381. https:\/\/doi.org\/10.1089\/can.2021.0162.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"10","key":"2201_CR49","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1089\/jwh.2020.8668","volume":"30","author":"M Armour","year":"2021","unstructured":"Armour M, Sinclair J, Noller G, Girling J, Larcombe M, Al-Dabbas MA, et al. Illicit cannabis usage as a management strategy in New Zealand women with endometriosis: an online survey. J Womens Health (Larchmt). 2021;30(10):1485\u201392. https:\/\/doi.org\/10.1089\/jwh.2020.8668.\u00a0","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"2201_CR50","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jogc.2019.08.033","volume":"42","author":"J Sinclair","year":"2020","unstructured":"Sinclair J, Smith CA, Abbott J, Chalmers KJ, Pate DW, Armour M. Cannabis use, a self-management strategy among Australian women with endometriosis: results from a national online survey. J Obstet Gynaecol Can. 2020;42(3):256\u201361. 033.","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"2201_CR51","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1089\/jwh.2020.8491","volume":"30","author":"L Han","year":"2021","unstructured":"Han L, Alton K, Colwill AC, Jensen JT, McCrimmon S, Darney BG. Willingness to use cannabis for gynecological conditions: a national survey. J Womens Health (Larchmt). 2021;30(3):438\u201344. https:\/\/doi.org\/10.1089\/jwh.2020.8491.\u00a0","journal-title":"J Womens Health (Larchmt)"},{"key":"2201_CR52","doi-asserted-by":"publisher","first-page":"816747","DOI":"10.3389\/fncir.2021.816747","volume":"15","author":"NJ van den Hoogen","year":"2021","unstructured":"van den Hoogen NJ, Harding EK, Davidson CED, Trang T. Cannabinoids in chronic pain: therapeutic potential through microglia modulation. Front Neural Circuits. 2021;15:816747. https:\/\/doi.org\/10.3389\/fncir.2021.816747","journal-title":"Front Neural Circuits"},{"key":"2201_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fphar.2015.00006","volume":"6","author":"K Befort","year":"2015","unstructured":"Befort K. Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies. Front Pharmacol. 2015;6:6. https:\/\/doi.org\/10.3389\/fphar.2015.00006","journal-title":"Front Pharmacol"},{"issue":"1","key":"2201_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1176\/appi.ajp.2021.21111138","volume":"179","author":"M Haney","year":"2022","unstructured":"Haney M. Cannabis use and the endocannabinoid system: a clinical perspective. Am J Psychiatry. 2022;179(1):21\u20135. https:\/\/doi.org\/10.1176\/appi.ajp.2021.21111138","journal-title":"Am J Psychiatry"},{"issue":"3","key":"2201_CR55","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.3390\/ijms24032513","volume":"24","author":"C Pagano","year":"2023","unstructured":"Pagano C, Savarese B, Coppola L, Navarra G, Avilia G, Laezza C, et al. Cannabinoids in the modulation of oxidative signaling. Int J Mol Sci. 2023;24(3):2513. https:\/\/doi.org\/10.3390\/ijms24032513","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2201_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/CU9.0000000000000023","volume":"15","author":"JL Capodice","year":"2021","unstructured":"Capodice JL, Kaplan SA. The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men\u2019s health. Curr Urol. 2021;15(2):95\u2013100. https:\/\/doi.org\/10.1097\/CU9.0000000000000023.","journal-title":"Curr Urol"},{"key":"2201_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7812\/TPP\/19.200","volume":"25","author":"S Chayasirisobhon","year":"2020","unstructured":"Chayasirisobhon S. Mechanisms of action and pharmacokinetics of cannabis. Perm J. 2020;25:1\u20133. https:\/\/doi.org\/10.7812\/TPP\/19.200","journal-title":"Perm J"},{"issue":"2","key":"2201_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/157015907780866884","volume":"5","author":"JC Ashton","year":"2007","unstructured":"Ashton JC, Glass M. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr Neuropharmacol. 2007;5(2):73\u201380. https:\/\/doi.org\/10.2174\/157015907780866884.","journal-title":"Curr Neuropharmacol"},{"issue":"17","key":"2201_CR59","doi-asserted-by":"publisher","first-page":"9407","DOI":"10.3390\/ijms25179407","volume":"25","author":"C Secondulfo","year":"2024","unstructured":"Secondulfo C, Mazzeo F, Pastorino GMG, Vicidomini A, Meccariello R, Operto FF. Opioid and cannabinoid systems in pain: emerging molecular mechanisms and use in clinical practice, health, and fitness. Int J Mol Sci. 2024;25(17):9407. https:\/\/doi.org\/10.3390\/ijms25179407","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2201_CR60","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/157015906778019527","volume":"4","author":"J Manzanares","year":"2006","unstructured":"Manzanares J, Julian M, Carrascosa A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol. 2006;4(3):239\u201357. https:\/\/doi.org\/10.2174\/157015906778019527","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"2201_CR61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jmig.2021.11.017","volume":"29","author":"M Mistry","year":"2022","unstructured":"Mistry M, Simpson P, Morris E, Fritz AK, Karavadra B, Lennox C, et al. Cannabidiol for the management of endometriosis and chronic pelvic pain. J Minim Invasive Gynecol. 2022;29(2):169\u201376.","journal-title":"J Minim Invasive Gynecol"},{"issue":"6","key":"2201_CR62","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/187152709789824660","volume":"8","author":"J Guindon","year":"2009","unstructured":"Guindon J, Hohmann AG. The endocannabinoid system and pain. CNS Neurol Disord Drug Targets. 2009;8(6):403\u201321. https:\/\/doi.org\/10.2174\/187152709789824660.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"2201_CR63","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/molecules29020410","volume":"29","author":"AK Al-Khazaleh","year":"2024","unstructured":"Al-Khazaleh AK, Zhou X, Bhuyan DJ, Munch GW, Al-Dalabeeh EA, Jaye K, et al. The neurotherapeutic arsenal in cannabis sativa: insights into anti-neuroinflammatory and neuroprotective activity and potential entourage effects. Molecules. 2024;29(2):410. https:\/\/doi.org\/10.3390\/molecules29020410","journal-title":"Molecules"},{"issue":"8","key":"2201_CR64","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.3390\/ijms25084204","volume":"25","author":"NM Blebea","year":"2024","unstructured":"Blebea NM, Pricopie AI, Vlad RA, Hancu G. Phytocannabinoids: exploring pharmacological profiles and their impact on therapeutical use. Int J Mol Sci. 2024;25(8):4204. https:\/\/doi.org\/10.3390\/ijms25084204","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2201_CR65","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bpsc.2020.07.016","volume":"6","author":"HC Lu","year":"2021","unstructured":"Lu HC, Mackie K. Review of the endocannabinoid system. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607\u201315. https:\/\/doi.org\/10.1016\/j.bpsc.2020.07.016.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"6","key":"2201_CR66","doi-asserted-by":"publisher","first-page":"e00682","DOI":"10.1002\/prp2.682","volume":"8","author":"DL de Almeida","year":"2020","unstructured":"de Almeida DL, Devi LA. Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect. 2020;8(6):e00682. https:\/\/doi.org\/10.1002\/prp2.682.\u00a0","journal-title":"Pharmacol Res Perspect"},{"key":"2201_CR67","doi-asserted-by":"publisher","first-page":"102438","DOI":"10.1016\/j.coph.2024.102438","volume":"75","author":"MA Hopkins","year":"2024","unstructured":"Hopkins MA, McGuire BE, Finn DP. Targeting the endocannabinoid system for the management of low back pain. Curr Opin Pharmacol. 2024;75:102438. https:\/\/doi.org\/10.1016\/j.coph.2024.102438.\u00a0","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"2201_CR68","doi-asserted-by":"publisher","first-page":"e10436","DOI":"10.7759\/cureus.10436","volume":"12","author":"AT Anthony","year":"2020","unstructured":"Anthony AT, Rahmat S, Sangle P, Sandhu O, Khan S. Cannabinoid receptors and their relationship with chronic pain: a narrative review. Cureus. 2020;12(9):e10436. https:\/\/doi.org\/10.7759\/cureus.10436.\u00a0","journal-title":"Cureus"},{"issue":"22","key":"2201_CR69","doi-asserted-by":"publisher","first-page":"e71255","DOI":"10.1096\/fj.202502415R","volume":"39","author":"M Raeispour","year":"2025","unstructured":"Raeispour M, Prisinzano M, Seidita I, Romeo L, Nardi E, Castiglione F, et al. S1P(3) receptor mediates the proinflammatory effect of the endocannabinoid 2-arachidonoylglycerol in endometriotic epithelial cells. FASEB J. 2025;39(22):e71255.","journal-title":"FASEB J"},{"issue":"1\u20132","key":"2201_CR70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0304-3959(01)00419-5","volume":"97","author":"WP Farquhar-Smith","year":"2002","unstructured":"Farquhar-Smith WP, Jaggar SI, Rice AS. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain. 2002;97(1\u20132):11\u201321. https:\/\/doi.org\/10.1016\/s0304-3959(01)00419-5","journal-title":"Pain"},{"key":"2201_CR71","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3389\/fphar.2018.01496","volume":"9","author":"R Guerrero-Alba","year":"2018","unstructured":"Guerrero-Alba R, Barragan-Iglesias P, Gonzalez-Hernandez A, Valdez-Morales EE, Granados-Soto V, Condes-Lara M, et al. Some prospective alternatives for treating pain: the endocannabinoid system and its putative receptors GPR18 and GPR55. Front Pharmacol. 2018;9:1496.","journal-title":"Front Pharmacol"},{"key":"2201_CR72","doi-asserted-by":"publisher","first-page":"118044","DOI":"10.1016\/j.biopha.2025.118044","volume":"186","author":"R Meanti","year":"2025","unstructured":"Meanti R, Bresciani E, Rizzi L, Molteni L, Coco S, Omeljaniuk RJ, et al. Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. Biomed Pharmacother. 2025;186:118044. https:\/\/doi.org\/10.1016\/j.biopha.2025.118044.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2201_CR73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/sj.bjp.0706984","volume":"150","author":"T Gutierrez","year":"2007","unstructured":"Gutierrez T, Farthing JN, Zvonok AM, Makriyannis A, Hohmann AG. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. Br J Pharmacol. 2007;150(2):153\u201363. https:\/\/doi.org\/10.1038\/sj.bjp.0706984.","journal-title":"Br J Pharmacol"},{"issue":"19","key":"2201_CR74","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1111\/bph.15208","volume":"177","author":"M McKenna","year":"2020","unstructured":"McKenna M, McDougall JJ. Cannabinoid control of neurogenic inflammation. Br J Pharmacol. 2020;177(19):4386\u201399. https:\/\/doi.org\/10.1111\/bph.15208.","journal-title":"Br J Pharmacol"},{"key":"2201_CR75","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2147\/JPR.S258433","volume":"13","author":"U Anand","year":"2020","unstructured":"Anand U, Jones B, Korchev Y, Bloom SR, Pacchetti B, Anand P, et al. CBD effects on TRPV1 signaling pathways in cultured DRG neurons. J Pain Res. 2020;13:2269\u201378. https:\/\/doi.org\/10.2147\/JPR.S258433.","journal-title":"J Pain Res"},{"issue":"4","key":"2201_CR76","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/s0306-4522(00)00389-4","volume":"100","author":"J Ahluwalia","year":"2000","unstructured":"Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience. 2000;100(4):685\u20138. https:\/\/doi.org\/10.1016\/s0306-4522(00)00389-4","journal-title":"Neuroscience"},{"issue":"8","key":"2201_CR77","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1517\/13543784.2014.918603","volume":"23","author":"MP Davis","year":"2014","unstructured":"Davis MP. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. Expert Opin Investig Drugs. 2014;23(8):1123\u201340. https:\/\/doi.org\/10.1517\/13543784.2014.918603.","journal-title":"Expert Opin Investig Drugs"},{"issue":"12","key":"2201_CR78","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/AJP.0000000000000509","volume":"33","author":"DN Lyons","year":"2017","unstructured":"Lyons DN, Zhang L, Danaher RJ, Miller CS, Westlund KN. PPARgamma agonists attenuate trigeminal neuropathic pain. Clin J Pain. 2017;33(12):1071\u201380. https:\/\/doi.org\/10.1097\/AJP.0000000000000509.","journal-title":"Clin J Pain"},{"issue":"1","key":"2201_CR79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.coph.2009.09.009","volume":"10","author":"I Bushlin","year":"2010","unstructured":"Bushlin I, Rozenfeld R, Devi LA. Cannabinoid-opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol. 2010;10(1):80\u20136. https:\/\/doi.org\/10.1016\/j.coph.2009.09.009.","journal-title":"Curr Opin Pharmacol"},{"issue":"7","key":"2201_CR80","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nn1916","volume":"10","author":"N Agarwal","year":"2007","unstructured":"Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, et al. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci. 2007;10(7):870\u20139. https:\/\/doi.org\/10.1038\/nn1916.\u00a0","journal-title":"Nat Neurosci"},{"issue":"2\u20133","key":"2201_CR81","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1054\/plef.2001.0362","volume":"66","author":"AS Rice","year":"2002","unstructured":"Rice AS, Farquhar-Smith WP, Nagy I. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fat Acids. 2002;66(2\u20133):243\u201356. https:\/\/doi.org\/10.1054\/plef.2001.0362.\u00a0","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"2201_CR82","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/bs.apha.2017.05.003","volume":"80","author":"K Starowicz","year":"2017","unstructured":"Starowicz K, Finn DP. Cannabinoids and pain: sites and mechanisms of action. Adv Pharmacol. 2017;80:437\u201375. https:\/\/doi.org\/10.1016\/bs.apha.2017.05.003.\u00a0","journal-title":"Adv Pharmacol"},{"key":"2201_CR83","doi-asserted-by":"publisher","unstructured":"Zou S, Kumar U. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci. 2018;19(3):833. https:\/\/doi.org\/10.3390\/ijms19030833.","DOI":"10.3390\/ijms19030833"},{"issue":"1","key":"2201_CR84","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/15504263.2019.1668100","volume":"16","author":"AL Milligan","year":"2020","unstructured":"Milligan AL, Szabo-Pardi TA, Burton MD. Cannabinoid receptor type 1 and its role as an analgesic: an opioid alternative? J Dual Diagn. 2020;16(1):106\u201319. https:\/\/doi.org\/10.1080\/15504263.2019.1668100.","journal-title":"J Dual Diagn"},{"issue":"1\u20132","key":"2201_CR85","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0009-3084(02)00155-x","volume":"121","author":"TP Malan Jr.","year":"2002","unstructured":"Malan TP Jr., Ibrahim MM, Vanderah TW, Makriyannis A, Porreca F. Inhibition of pain responses by activation of CB(2) cannabinoid receptors. Chem Phys Lipids. 2002;121(1\u20132):191\u2013200. https:\/\/doi.org\/10.1016\/s0009-3084(02)00155-x","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"2201_CR86","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12035-007-8007-7","volume":"36","author":"MD Jhaveri","year":"2007","unstructured":"Jhaveri MD, Sagar DR, Elmes SJ, Kendall DA, Chapman V. Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain. Mol Neurobiol. 2007;36(1):26\u201335. https:\/\/doi.org\/10.1007\/s12035-007-8007-7.","journal-title":"Mol Neurobiol"},{"key":"2201_CR87","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S1462399409000957","volume":"11","author":"GA Cabral","year":"2009","unstructured":"Cabral GA, Griffin-Thomas L. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med. 2009;11:e3. https:\/\/doi.org\/10.1017\/S1462399409000957.","journal-title":"Expert Rev Mol Med"},{"issue":"2","key":"2201_CR88","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","volume":"153","author":"C Benito","year":"2008","unstructured":"Benito C, Tolon RM, Pazos MR, Nunez E, Castillo AI, Romero J. Cannabinoid CB2 receptors in human brain inflammation. Br J Pharmacol. 2008;153(2):277\u201385. https:\/\/doi.org\/10.1038\/sj.bjp.0707505.\u00a0","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2201_CR89","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/ACO.0000000000000616","volume":"31","author":"B Bie","year":"2018","unstructured":"Bie B, Wu J, Foss JF, Naguib M. An overview of the cannabinoid type 2 receptor system and its therapeutic potential. Curr Opin Anaesthesiol. 2018;31(4):407\u201314. https:\/\/doi.org\/10.1097\/ACO.0000000000000616.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"17","key":"2201_CR90","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.3390\/ijms231710016","volume":"23","author":"K Louis-Gray","year":"2022","unstructured":"Louis-Gray K, Tupal S, Premkumar LS. TRPV1: a common denominator mediating antinociceptive and antiemetic effects of cannabinoids. Int J Mol Sci. 2022;23(17):10016. https:\/\/doi.org\/10.3390\/ijms231710016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2201_CR91","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","volume":"143","author":"B Costa","year":"2004","unstructured":"Costa B, Giagnoni G, Franke C, Trovato AE, Colleoni M. Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. Br J Pharmacol. 2004;143(2):247\u201350. https:\/\/doi.org\/10.1038\/sj.bjp.0705920.\u00a0","journal-title":"Br J Pharmacol"},{"key":"2201_CR92","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2013.06.066","volume":"551","author":"TS McDowell","year":"2013","unstructured":"McDowell TS, Wang ZY, Singh R, Bjorling D. CB1 cannabinoid receptor agonist prevents NGF-induced sensitization of TRPV1 in sensory neurons. Neurosci Lett. 2013;551:34\u20138. https:\/\/doi.org\/10.1016\/j.neulet.2013.06.066.\u00a0","journal-title":"Neurosci Lett"},{"issue":"4","key":"2201_CR93","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2217\/pmt-2020-0110","volume":"11","author":"U Anand","year":"2021","unstructured":"Anand U, Pacchetti B, Anand P, Sodergren MH. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects. Pain Manag. 2021;11(4):395\u2013403. https:\/\/doi.org\/10.2217\/pmt-2020-0110.\u00a0","journal-title":"Pain Manag"},{"key":"2201_CR94","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.neuropharm.2013.01.020","volume":"70","author":"J Morgenweck","year":"2013","unstructured":"Morgenweck J, Griggs RB, Donahue RR, Zadina JE, Taylor BK. PPARgamma activation blocks development and reduces established neuropathic pain in rats. Neuropharmacology. 2013;70:236\u201346. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.01.020.\u00a0","journal-title":"Neuropharmacology"},{"issue":"16","key":"2201_CR95","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.3390\/molecules28165980","volume":"28","author":"N Martinez Naya","year":"2023","unstructured":"Martinez Naya N, Kelly J, Corna G, Golino M, Abbate A, Toldo S. Molecular and cellular mechanisms of action of cannabidiol. Molecules. 2023;28(16):5980. https:\/\/doi.org\/10.3390\/molecules28165980","journal-title":"Molecules"},{"issue":"2","key":"2201_CR96","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/ph16020155","volume":"16","author":"M Luz-Veiga","year":"2023","unstructured":"Luz-Veiga M, Azevedo-Silva J, Fernandes JC. Beyond pain relief: a review on cannabidiol potential in medical therapies. Pharmaceuticals (Basel). 2023;16(2):155. https:\/\/doi.org\/10.3390\/ph16020155","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"2201_CR97","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.acthis.2017.05.005","volume":"119","author":"E Bilgic","year":"2017","unstructured":"Bilgic E, Guzel E, Kose S, Aydin MC, Karaismailoglu E, Akar I, et al. Endocannabinoids modulate apoptosis in endometriosis and adenomyosis. Acta Histochem. 2017;119(5):523\u201332. https:\/\/doi.org\/10.1016\/j.acthis.2017.05.005.\u00a0","journal-title":"Acta Histochem"},{"key":"2201_CR98","doi-asserted-by":"publisher","first-page":"5468954","DOI":"10.1155\/2019\/5468954","volume":"2019","author":"X Shen","year":"2019","unstructured":"Shen X, Duan H, Wang S, Gan L, Xu Q, Li JJ. Decreased expression of cannabinoid receptors in the eutopic and ectopic endometrium of patients with adenomyosis. Biomed Res Int. 2019;2019:5468954. https:\/\/doi.org\/10.1155\/2019\/5468954.\u00a0","journal-title":"Biomed Res Int"},{"issue":"1","key":"2201_CR99","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s42238-025-00275-x","volume":"7","author":"K Tanaka","year":"2025","unstructured":"Tanaka K, Amoako AA, Mortlock S, Rogers PAW, Holdsworth-Carson SJ, Donoghue JF, et al. The influence of genetics on the endocannabinoid system gene expression and relevance for targeting reproductive conditions. J Cannabis Res. 2025;7(1):29. https:\/\/doi.org\/10.1186\/s42238-025-00275-x.\u00a0","journal-title":"J Cannabis Res"},{"issue":"8","key":"2201_CR100","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1177\/1933719116630414","volume":"23","author":"AM Sanchez","year":"2016","unstructured":"Sanchez AM, Cioffi R, Vigano P, Candiani M, Verde R, Piscitelli F, et al. Elevated systemic levels of endocannabinoids and related mediators across the menstrual cycle in women with endometriosis. Reprod Sci. 2016;23(8):1071\u20139. https:\/\/doi.org\/10.1177\/1933719116630414.","journal-title":"Reprod Sci"},{"issue":"1","key":"2201_CR101","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/humrep\/dew281","volume":"32","author":"AM Sanchez","year":"2017","unstructured":"Sanchez AM, Quattrone F, Pannese M, Ulisse A, Candiani M, Diaz-Alonso J, et al. The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis. Hum Reprod. 2017;32(1):175\u201384. https:\/\/doi.org\/10.1093\/humrep\/dew281.\u00a0","journal-title":"Hum Reprod"},{"key":"2201_CR102","doi-asserted-by":"publisher","first-page":"726936","DOI":"10.3389\/frph.2021.726936","volume":"3","author":"H Lingegowda","year":"2021","unstructured":"Lingegowda H, Miller JE, Marks RM, Symons LK, Alward T, Lomax AE, et al. Synthetic cannabinoid agonist WIN 55212-2 targets proliferation, angiogenesis, and apoptosis via MAPK\/AKT signaling in human endometriotic cell lines and a murine model of endometriosis. Front Reprod Health. 2021;3:726936.","journal-title":"Front Reprod Health"},{"issue":"6","key":"2201_CR103","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.2353\/ajpath.2010.100375","volume":"177","author":"M Leconte","year":"2010","unstructured":"Leconte M, Nicco C, Ngo C, Arkwright S, Chereau C, Guibourdenche J, et al. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol. 2010;177(6):2963\u201370. https:\/\/doi.org\/10.2353\/ajpath.2010.100375.\u00a0","journal-title":"Am J Pathol"},{"issue":"5","key":"2201_CR104","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.rbmo.2023.01.018","volume":"46","author":"SB Okten","year":"2023","unstructured":"Okten SB, Cetin C, Tok OE, Guler EM, Taha SH, Ozcan P, et al. Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model. Reprod Biomed Online. 2023;46(5):865\u201375. https:\/\/doi.org\/10.1016\/j.rbmo.2023.01.018.\u00a0","journal-title":"Reprod Biomed Online"},{"key":"2201_CR105","doi-asserted-by":"publisher","first-page":"e50356","DOI":"10.7554\/eLife.50356","volume":"9","author":"A Escudero-Lara","year":"2020","unstructured":"Escudero-Lara A, Argerich J, Cabanero D, Maldonado R. Disease-modifying effects of natural Delta9-tetrahydrocannabinol in endometriosis-associated pain. Elife. 2020;9:e50356. https:\/\/doi.org\/10.7554\/eLife.50356","journal-title":"Elife"},{"issue":"3","key":"2201_CR106","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.pain","volume":"151","author":"N Dmitrieva","year":"2010","unstructured":"Dmitrieva N, Nagabukuro H, Resuehr D, Zhang G, McAllister SL, McGinty KA, et al. Endocannabinoid involvement in endometriosis. Pain. 2010;151(3):703\u201310. https:\/\/doi.org\/10.1016\/j.pain.\u00a0","journal-title":"Pain"},{"key":"2201_CR107","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.2147\/JPR.S459584","volume":"17","author":"E Kirsch","year":"2024","unstructured":"Kirsch E, Rahman S, Kerolus K, Hasan R, Kowalska DB, Desai A, et al. Dysmenorrhea, a narrative review of therapeutic options. J Pain Res. 2024;17:2657\u201366. https:\/\/doi.org\/10.2147\/JPR.S459584.","journal-title":"J Pain Res"},{"issue":"4","key":"2201_CR108","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humupd\/dmaa005","volume":"26","author":"J Maia","year":"2020","unstructured":"Maia J, Fonseca BM, Teixeira N, Correia-da-Silva G. The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders. Hum Reprod Update. 2020;26(4):586\u2013602. https:\/\/doi.org\/10.1093\/humupd\/dmaa005.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2201_CR109","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-12-0182","volume":"50","author":"AM Di Blasio","year":"2013","unstructured":"Di Blasio AM, Vignali M, Gentilini D. The endocannabinoid pathway and the female reproductive organs. J Mol Endocrinol. 2013;50(1):R1\u20139. https:\/\/doi.org\/10.1530\/JME-12-0182.\u00a0","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"2201_CR110","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3390\/biom14121627","volume":"14","author":"R Bonanni","year":"2024","unstructured":"Bonanni R, Ratano P, Cariati I, Tancredi V, Cifelli P. Treatment strategies for painful pelvic floor conditions: a focus on the potential benefits of cannabidiol. Biomolecules. 2024;14(12):1627. https:\/\/doi.org\/10.3390\/biom14121627","journal-title":"Biomolecules"},{"issue":"22","key":"2201_CR111","doi-asserted-by":"publisher","first-page":"11132","DOI":"10.3390\/ijms262211132","volume":"26","author":"M Serban","year":"2025","unstructured":"Serban M, Toader C, Covache-Busuioc RA. The endocannabinoid system in human disease: molecular signaling, receptor pharmacology, and therapeutic innovation. Int J Mol Sci. 2025;26(22):11132. https:\/\/doi.org\/10.3390\/ijms262211132","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2201_CR112","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/22840265211011277","volume":"13","author":"I Marcu","year":"2021","unstructured":"Marcu I, Gee A, Lynn B. Cannabinoids and chronic pelvic pain in women: Focus on endometriosis. J Endometr Pelvic Pain Disorders. 2021;13(3):155\u201365. https:\/\/doi.org\/10.1177\/22840265211011277.","journal-title":"J Endometr Pelvic Pain Disorders"},{"issue":"2","key":"2201_CR113","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3892\/mmr.2017.6783","volume":"16","author":"YL Lian","year":"2017","unstructured":"Lian YL, Cheng MJ, Zhang XX, Wang L. Elevated expression of transient receptor potential vanilloid type 1 in dorsal root ganglia of rats with endometriosis. Mol Med Rep. 2017;16(2):1920\u20136. https:\/\/doi.org\/10.3892\/mmr.2017.6783.","journal-title":"Mol Med Rep"},{"issue":"2","key":"2201_CR114","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tips.2008.10.008","volume":"30","author":"AN Akopian","year":"2009","unstructured":"Akopian AN, Ruparel NB, Jeske NA, Patwardhan A, Hargreaves KM. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. Trends Pharmacol Sci. 2009;30(2):79\u201384. https:\/\/doi.org\/10.1016\/j.tips.2008.10.008.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"2201_CR115","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","volume":"238","author":"SC Britch","year":"2021","unstructured":"Britch SC, Babalonis S, Walsh SL. Cannabidiol: pharmacology and therapeutic targets. Psychopharmacology. 2021;238(1):9\u201328. https:\/\/doi.org\/10.1007\/s00213-020-05712-8.","journal-title":"Psychopharmacology"},{"key":"2201_CR116","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbrc.2023.04","volume":"660","author":"DD Aguiar","year":"2023","unstructured":"Aguiar DD, da Costa Oliveira C, Fonseca FCS, de Almeida DL, Campos Pereira WV, Guimaraes FS, et al. Peripherally injected canabidiol reduces neuropathic pain in mice: Role of the 5-HT(1A) and TRPV1 receptors. Biochem Biophys Res Commun. 2023;660:58\u201364. https:\/\/doi.org\/10.1016\/j.bbrc.2023.04.\u00a0","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2201_CR117","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/1933719110391279","volume":"18","author":"MG Rocha","year":"2011","unstructured":"Rocha MG, e Silva JC, Ribeiro da Silva A, Candido Dos Reis FJ, Nogueira AA, Poli-Neto OB. TRPV1 expression on peritoneal endometriosis foci is associated with chronic pelvic pain. Reprod Sci. 2011;18(6):511\u20135. https:\/\/doi.org\/10.1177\/1933719110391279.","journal-title":"Reprod Sci"},{"issue":"4","key":"2201_CR118","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3390\/ijms26041770","volume":"26","author":"Y Chen","year":"2025","unstructured":"Chen Y, Li T. Unveiling the mechanisms of pain in endometriosis: comprehensive analysis of inflammatory sensitization and therapeutic potential. Int J Mol Sci. 2025;26(4):1770. https:\/\/doi.org\/10.3390\/ijms26041770.\u00a0","journal-title":"Int J Mol Sci"},{"key":"2201_CR119","doi-asserted-by":"publisher","first-page":"111942","DOI":"10.1016\/j.intimp.2024.111942","volume":"132","author":"T Mokhtari","year":"2024","unstructured":"Mokhtari T, Irandoost E, Sheikhbahaei F. Stress, pain, anxiety, and depression in endometriosis-Targeting glial activation and inflammation. Int Immunopharmacol. 2024;132:111942. https:\/\/doi.org\/10.1016\/j.intimp.2024.111942.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2201_CR120","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","volume":"141","author":"L Walter","year":"2004","unstructured":"Walter L, Stella N. Cannabinoids and neuroinflammation. Br J Pharmacol. 2004;141(5):775\u201385. https:\/\/doi.org\/10.1038\/sj.bjp.0705667.\u00a0","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2201_CR121","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12974-023-02713-0","volume":"20","author":"ST Bashir","year":"2023","unstructured":"Bashir ST, Redden CR, Raj K, Arcanjo RB, Stasiak S, Li Q, et al. Endometriosis leads to central nervous system-wide glial activation in a mouse model of endometriosis. J Neuroinflammation. 2023;20(1):59. https:\/\/doi.org\/10.1186\/s12974-023-02713-0.\u00a0","journal-title":"J Neuroinflammation"},{"key":"2201_CR122","doi-asserted-by":"publisher","first-page":"1691428","DOI":"10.1155\/2018\/1691428","volume":"2018","author":"F Pellati","year":"2018","unstructured":"Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L. Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer. Biomed Res Int. 2018;2018:1691428. https:\/\/doi.org\/10.1155\/2018\/1691428.\u00a0","journal-title":"Biomed Res Int"},{"issue":"46","key":"2201_CR123","doi-asserted-by":"publisher","first-page":"12125","DOI":"10.1523\/JNEUROSCI.3400-08.2008","volume":"28","author":"I Racz","year":"2008","unstructured":"Racz I, Nadal X, Alferink J, Banos JE, Rehnelt J, Martin M, et al. Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J Neurosci. 2008;28(46):12125\u201335.","journal-title":"J Neurosci"},{"issue":"3","key":"2201_CR124","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.3390\/ijms24032348","volume":"24","author":"K Xu","year":"2023","unstructured":"Xu K, Wu Y, Tian Z, Xu Y, Wu C, Wang Z. Microglial cannabinoid CB(2) receptors in pain modulation. Int J Mol Sci. 2023;24(3):2348. https:\/\/doi.org\/10.3390\/ijms24032348","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2201_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tem.2014.10.003","volume":"26","author":"BD McKinnon","year":"2015","unstructured":"McKinnon BD, Bertschi D, Bersinger NA, Mueller MD. Inflammation and nerve fiber interaction in endometriotic pain. Trends Endocrinol Metab. 2015;26(1):1\u201310. https:\/\/doi.org\/10.1016\/j.tem.2014.10.003.\u00a0","journal-title":"Trends Endocrinol Metab"},{"key":"2201_CR126","doi-asserted-by":"publisher","first-page":"1329406","DOI":"10.3389\/fmed.2024.1329406","volume":"11","author":"I Psilopatis","year":"2024","unstructured":"Psilopatis I, Theocharis S, Beckmann MW. The role of peroxisome proliferator-activated receptors in endometriosis. Front Med (Lausanne). 2024;11:1329406. https:\/\/doi.org\/10.3389\/fmed.2024.1329406.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"2201_CR127","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/cells10030586","volume":"10","author":"FA Iannotti","year":"2021","unstructured":"Iannotti FA, Vitale RM. The endocannabinoid system and PPARs: focus on their signalling crosstalk, action and transcriptional regulation. Cells. 2021;10(3):586. https:\/\/doi.org\/10.3390\/cells10030586","journal-title":"Cells"},{"key":"2201_CR128","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejogrb.2019.11.012","volume":"244","author":"K Tanaka","year":"2020","unstructured":"Tanaka K, Mayne L, Khalil A, Baartz D, Eriksson L, Mortlock SA, et al. The role of the endocannabinoid system in aetiopathogenesis of endometriosis: A potential therapeutic target. Eur J Obstet Gynecol Reprod Biol. 2020;244:87\u201394.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2201_CR129","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","volume":"9","author":"S Vuckovic","year":"2018","unstructured":"Vuckovic S, Srebro D, Vujovic KS, Vucetic C, Prostran M. Cannabinoids and pain: new insights from old molecules. Front Pharmacol. 2018;9:1259. https:\/\/doi.org\/10.3389\/fphar.2018.01259.","journal-title":"Front Pharmacol"},{"key":"2201_CR130","doi-asserted-by":"publisher","first-page":"RP96523","DOI":"10.7554\/eLife.96523","volume":"13","author":"H Lingegowda","year":"2024","unstructured":"Lingegowda H, Zutautas KB, Wei Y, Yolmo P, Sisnett DJ, McCallion A, et al. Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response. Elife. 2024;13:RP96523. https:\/\/doi.org\/10.7554\/eLife.96523","journal-title":"Elife"},{"key":"2201_CR131","doi-asserted-by":"publisher","first-page":"100463","DOI":"10.1016\/j.jadr.2023.100463","volume":"12","author":"BE Leonard","year":"2023","unstructured":"Leonard BE, Aricioglu F. Cannabinoids and neuroinflammation: Therapeutic implications. J Affect Disorders Rep. 2023;12:100463. https:\/\/doi.org\/10.1016\/j.jadr.2023.100463.","journal-title":"J Affect Disorders Rep"},{"issue":"1","key":"2201_CR132","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/molecules27010064","volume":"27","author":"A Capozzi","year":"2021","unstructured":"Capozzi A, Caissutti D, Mattei V, Gado F, Martellucci S, Longo A, et al. Anti-inflammatory activity of a CB2 selective cannabinoid receptor agonist: signaling and cytokines release in blood mononuclear cells. Molecules. 2021;27(1):64. https:\/\/doi.org\/10.3390\/molecules27010064","journal-title":"Molecules"},{"issue":"Suppl 1","key":"2201_CR133","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2826.2008.01674","volume":"20","author":"D De Filippis","year":"2008","unstructured":"De Filippis D, D\u2019Amico A, Iuvone T Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol. 2008;20(Suppl 1):20\u20135. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01674.","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"2201_CR134","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/biomedicines9010054","volume":"9","author":"N Machairiotis","year":"2021","unstructured":"Machairiotis N, Vasilakaki S, Thomakos N. Inflammatory mediators and pain in endometriosis: a systematic review. Biomedicines. 2021;9(1):54. https:\/\/doi.org\/10.3390\/biomedicines9010054.","journal-title":"Biomedicines"},{"key":"2201_CR135","doi-asserted-by":"publisher","first-page":"613613","DOI":"10.3389\/fimmu.2020.613613","volume":"11","author":"SV Suryavanshi","year":"2020","unstructured":"Suryavanshi SV, Kovalchuk I, Kovalchuk O. Cannabinoids as key regulators of inflammasome signaling: a current perspective. Front Immunol. 2020;11:613613. Epub 20210128. https:\/\/doi.org\/10.3389\/fimmu.2020.613613.","journal-title":"Front Immunol"},{"issue":"4","key":"2201_CR136","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/antiox11040660","volume":"11","author":"DM Kopustinskiene","year":"2022","unstructured":"Kopustinskiene DM, Masteikova R, Lazauskas R, Bernatoniene J. Cannabis sativa L. bioactive compounds and their protective role in oxidative stress and inflammation. Antioxid (Basel). 2022;11(4):660. https:\/\/doi.org\/10.3390\/antiox11040660","journal-title":"Antioxid (Basel)"},{"issue":"22","key":"2201_CR137","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.3390\/ijms21228870","volume":"21","author":"J Mlost","year":"2020","unstructured":"Mlost J, Bryk M, Starowicz K. Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int J Mol Sci. 2020;21(22):8870. https:\/\/doi.org\/10.3390\/ijms21228870","journal-title":"Int J Mol Sci"},{"key":"2201_CR138","doi-asserted-by":"publisher","first-page":"1106771","DOI":"10.3389\/fimmu.2023.1106771","volume":"14","author":"X Xu","year":"2023","unstructured":"Xu X, Wang J, Guo X, Chen Y, Ding S, Zou G, et al. GPR30-mediated non-classic estrogen pathway in mast cells participates in endometriosis pain via the production of FGF2. Front Immunol. 2023;14:1106771. https:\/\/doi.org\/10.3389\/fimmu.2023.1106771.\u00a0","journal-title":"Front Immunol"},{"issue":"17","key":"2201_CR139","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1080\/14656566.2024.2425727","volume":"25","author":"JV Pergolizzi Jr","year":"2024","unstructured":"Pergolizzi JV Jr., LeQuang JA, Coluzzi F, El-Tallawy SN, Magnusson P, Ahmed RS, et al. Managing the neuroinflammatory pain of endometriosis in light of chronic pelvic pain. Expert Opin Pharmacother. 2024;25(17):2267\u201382.","journal-title":"Expert Opin Pharmacother"},{"key":"2201_CR140","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1100\/tsw.2011.84","volume":"11","author":"EJ Downer","year":"2011","unstructured":"Downer EJ. Cannabinoids and innate immunity: taking a toll on neuroinflammation. ScientificWorldJournal. 2011;11:855\u201365. https:\/\/doi.org\/10.1100\/tsw.2011.84.","journal-title":"ScientificWorldJournal"},{"issue":"4","key":"2201_CR141","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.2741\/220","volume":"3","author":"M Nishida","year":"2011","unstructured":"Nishida M, Nasu K, Narahara H. Role of chemokines in the pathogenesis of endometriosis. Front Biosci (Schol Ed). 2011;3(4):1196\u2013204.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"4","key":"2201_CR142","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/00000542-200310000-00031","volume":"99","author":"A Quartilho","year":"2003","unstructured":"Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, et al. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology. 2003;99(4):955\u201360. https:\/\/doi.org\/10.1097\/00000542-200310000-00031.","journal-title":"Anesthesiology"},{"issue":"5","key":"2201_CR143","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/humupd\/dmz018","volume":"25","author":"J Vallve-Juanico","year":"2019","unstructured":"Vallve-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update. 2019;25(5):564\u201391. https:\/\/doi.org\/10.1093\/humupd\/dmz018.","journal-title":"Hum Reprod Update"},{"issue":"10","key":"2201_CR144","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1096\/fba.2021-00063","volume":"3","author":"SK Godin","year":"2021","unstructured":"Godin SK, Wagner J, Huang P, Bree D. The role of peripheral nerve signaling in endometriosis. FASEB Bioadv. 2021;3(10):802\u201313. https:\/\/doi.org\/10.1096\/fba.2021-00063.\u00a0","journal-title":"FASEB Bioadv"},{"issue":"4","key":"2201_CR145","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.bcp.2011.05.004","volume":"82","author":"G Cantarella","year":"2011","unstructured":"Cantarella G, Scollo M, Lempereur L, Saccani-Jotti G, Basile F, Bernardini R. Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells. Biochem Pharmacol. 2011;82(4):380\u20138. https:\/\/doi.org\/10.1016\/j.bcp.2011.05.004.\u00a0","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"2201_CR146","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.3390\/ijms24054254","volume":"24","author":"J Lamceva","year":"2023","unstructured":"Lamceva J, Uljanovs R, Strumfa I. The main theories on the pathogenesis of endometriosis. Int J Mol Sci. 2023;24(5):4254. https:\/\/doi.org\/10.3390\/ijms24054254","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2201_CR147","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/molehr\/gas037","volume":"18","author":"AM Sanchez","year":"2012","unstructured":"Sanchez AM, Vigano P, Mugione A, Panina-Bordignon P, Candiani M. The molecular connections between the cannabinoid system and endometriosis. Mol Hum Reprod. 2012;18(12):563\u201371. https:\/\/doi.org\/10.1093\/molehr\/gas037.\u00a0","journal-title":"Mol Hum Reprod"},{"key":"2201_CR148","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bpobgyn.2022.07.002","volume":"85","author":"NL Eichorn","year":"2022","unstructured":"Eichorn NL, Shult HT, Kracht KD, Berlau DJ. Making a joint decision: Cannabis as a potential substitute for opioids in obstetrics and gynecology. Best Pract Res Clin Obstet Gynecol. 2022;85:59\u201367. https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.07.002.","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"issue":"6","key":"2201_CR149","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/pds.5209","volume":"30","author":"SE Chiuve","year":"2021","unstructured":"Chiuve SE, Kilpatrick RD, Hornstein MD, Petruski-Ivleva N, Wegrzyn LR, Dabrowski EC, et al. Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims. Pharmacoepidemiol Drug Saf. 2021;30(6):787\u201396. https:\/\/doi.org\/10.1002\/pds.5209.\u00a0","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"2201_CR150","doi-asserted-by":"publisher","first-page":"e230049","DOI":"10.1530\/RAF-23-0049","volume":"4","author":"J Sinclair","year":"2023","unstructured":"Sinclair J, Abbott J, Mikocka-Walus A, Ng CHM, Sarris J, Evans S, et al. A glimmer of hope - Perceptions, barriers, and drivers for medicinal cannabis use amongst Australian and New Zealand people with endometriosis. Reprod Fertil. 2023;4(4):e230049. https:\/\/doi.org\/10.1530\/RAF-23-0049","journal-title":"Reprod Fertil"},{"issue":"1\u20132","key":"2201_CR151","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1615\/critrevneurobiol.v16.i12.170","volume":"16","author":"J Corchero","year":"2004","unstructured":"Corchero J, Manzanares J, Fuentes JA. Cannabinoid\/opioid crosstalk in the central nervous system. Crit Rev Neurobiol. 2004;16(1\u20132):159\u201372. https:\/\/doi.org\/10.1615\/critrevneurobiol.v16.i12.170.","journal-title":"Crit Rev Neurobiol"},{"issue":"7","key":"2201_CR152","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/s41386-022-01322-4","volume":"47","author":"S Nielsen","year":"2022","unstructured":"Nielsen S, Picco L, Murnion B, Winters B, Matheson J, Graham M, et al. Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies. Neuropsychopharmacology. 2022;47(7):1315\u201330. https:\/\/doi.org\/10.1038\/s41386-022-01322-4.","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"2201_CR153","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1517\/13543784.14.6.695","volume":"14","author":"A Fox","year":"2005","unstructured":"Fox A, Bevan S. Therapeutic potential of cannabinoid receptor agonists as analgesic agents. Expert Opin Investig Drugs. 2005;14(6):695\u2013703. 695.","journal-title":"Expert Opin Investig Drugs"},{"issue":"6 Suppl 3","key":"2201_CR154","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.5489\/cuaj.5331","volume":"12","author":"JC Nickel","year":"2018","unstructured":"Nickel JC. Medical marijuana for urologic chronic pelvic pain. Can Urol Assoc J. 2018;12(6 Suppl 3):S181\u20133. https:\/\/doi.org\/10.5489\/cuaj.5331","journal-title":"Can Urol Assoc J"},{"key":"2201_CR155","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2018.01","volume":"49","author":"CA MacCallum","year":"2018","unstructured":"MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12\u20139. https:\/\/doi.org\/10.1016\/j.ejim.2018.01.\u00a0","journal-title":"Eur J Intern Med"},{"issue":"7","key":"2201_CR156","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1517\/13543784.16.7.951","volume":"16","author":"Y Cheng","year":"2007","unstructured":"Cheng Y, Hitchcock SA. Targeting cannabinoid agonists for inflammatory and neuropathic pain. Expert Opin Investig Drugs. 2007;16(7):951\u201365. https:\/\/doi.org\/10.1517\/13543784.16.7.951","journal-title":"Expert Opin Investig Drugs"},{"issue":"8057","key":"2201_CR157","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-025-08618-7","volume":"640","author":"VA Rangari","year":"2025","unstructured":"Rangari VA, O\u2019Brien ES, Powers AS, Slivicki RA, Bertels Z, Appourchaux K, et al. A cryptic pocket in CB1 drives peripheral and functional selectivity. Nature. 2025;640(8057):265\u201373. https:\/\/doi.org\/10.1038\/s41586-025-08618-7.","journal-title":"Nature"},{"issue":"4","key":"2201_CR158","doi-asserted-by":"publisher","first-page":"e2416886122","DOI":"10.1073\/pnas.2416886122","volume":"122","author":"M-R Ghovanloo","year":"2025","unstructured":"Ghovanloo M-R, Tyagi S, Zhao P, Waxman SG. Nav1.8, an analgesic target for nonpsychotomimetic phytocannabinoids. Proc Natl Acad Sci. 2025;122(4):e2416886122. https:\/\/doi.org\/10.1073\/pnas.2416886122.","journal-title":"Proc Natl Acad Sci"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02201-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02201-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02201-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:45:14Z","timestamp":1791387914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-026-02201-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":158,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2201"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02201-9","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required. This research did not involve human or animal participants.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}